The decision making process behind adopting a new treatment

The Context

A global pharmaceutical company wants to assess the potential market opportunity for an advanced treatment designed for 2 Rheumatic conditions.

Business Challenge

The new treatment was only introduced two years into the diagnosis, the client is uncertain whether patients will be open to switching from the standard treatment.

Our Approach

In depth interviews with both patients and providers revealed that the existing treatment is deeply flawed and that patients will gain maximum benefit from the advanced drug as a first line of treatment.

APPROACH HIGHLIGHTS

Motivational Interviewing  was leveraged to recognize why people choose not to engage in a behaviour and what it would take for them to initiate a behaviour change.

Our Impact

Armed with a deep understanding of (i) patient & provider reaction to treatment profile; (ii) hesitance and inertia to switch from the existing treatment; (iii) early adopters,  we identified potential enablers and barriers to switching to a new treatment for both Rheumatic conditions.

character 1
character 2
character 3
character 4
character 5
character 6

character 1
character 2
character 3
character 4
character 7
character 6

character 1
character 2
character 3
character 4
character 1
character 6

This is very exciting and gives us confidence as we prepare for launch.

- Director, Commercial Development

Creating a Human Centric Blueprint for Website Design

Using behavioral sciences to create concepts that inspire HCP action

New Therapy Service Concepts to Elevate Patient Experience

The complex relationship with our skin.

The power of questioning to shift organizational mindset

Patient-Centric Design: The Auto-Injection Experience

A Roadmap to New Indications in Gastroenterology

Is an app the right solution for HIV weight gain?

Optimizing narrative to drive brand choice with physicians

Let’s Get In Touch!

Contact us